Definitely possible as the:
1) financials for the year end will drop shortly
2) we can expect an "executive summary/ conference call" from CEO to follow describing whats happening. Do they now own 20% or 25% or 30% or even more of the total cash flow in Oregon testing?... This will be a big indication of whether the "spoke and hub" model and EVIOs ability to get and retain customers is working. That market efficiency and intel will make their implementation worldwide that much easier with wins under your belt in a sector where nobody else even has pants. *Remember - their largest competitor in Eugene got taken out when it was reveled she was a NAZI/White Supremacist supporter. How the California rollout is progressing. Colorado. Costa Mesa CA developments. Whats happening in Florida and the lab in Boston area
3) - and this imho might be the biggest factor at play that a lot peeps on the board apparently have forgotten..... Dec 29 was the close for the announced $3,000,000 raise to fund the California and other expansion... rumors are swirling that not only weas the raise successfull but possibly massively oversubscribed wish is why they havent made an announcement yet - Major financial backers perhaps - household type brand name financiers making stakes in the sector -
4) Pfizer exec hire for President likely to be the precursor for a name brand notable board member... think ex politician/university chancellor type..
Any one of these could drop this week... likeliest is #3 followed by number 1 with number 2 on the list not likely this week but def have impact once Oregons growth hints are made...?
There is a TON of possible news. The interest, volume and awareness of EVIO as the play to make in cannabis (cause they are actually "testing labs" and dont "touch the leaf") means the pop up to irrationally exuberant price marks is only inevitable - whether its this week, this month or this quarter. imho buy now and hold on for the ride of your life.
News 
Market Data 
Discover 
